Related references
Note: Only part of the references are listed.Chromatin dysregulation associated with NSD1 mutation in head and neck squamous cell carcinoma
Nargess Farhangdoost et al.
CELL REPORTS (2021)
H3K36 Methylation in Neural Development and Associated Diseases
Mattia Zaghi et al.
FRONTIERS IN GENETICS (2020)
Global Regulation of the Histone Mark H3K36me2 Underlies Epithelial Plasticity and Metastatic Progression
Salina Yuan et al.
CANCER DISCOVERY (2020)
Covalent inhibition of NSD1 histone methyltransferase
Huang Huang et al.
NATURE CHEMICAL BIOLOGY (2020)
Targeted Inhibition of the NUP98-NSD1 Fusion Oncogene in Acute Myeloid Leukemia
Sagarajit Mohanty et al.
CANCERS (2020)
Extended transcriptome analysis reveals genome-wide lncRNA-mediated epigenetic dysregulation in colorectal cancer
Sha He et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2020)
Androgen receptor co-regulation in prostate cancer
Dhirodatta Senapati et al.
ASIAN JOURNAL OF UROLOGY (2020)
Successful treatment of acute myeloid leukemia co-expressing NUP98/NSD1 and FLT3/ITD with preemptive donor lymphocyte infusions
Yuichi Mitani et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2019)
Heterogeneity in refractory acute myeloid leukemia
Sachi Horibata et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Epigenetics in cancer therapy and nanomedicine
Annalisa Roberti et al.
CLINICAL EPIGENETICS (2019)
The Role of HOX Transcription Factors in Cancer Predisposition and Progression
Bo Li et al.
CANCERS (2019)
Expression and prognostic value of NSD1 and SETD2 in pancreatic ductal adenocarcinoma and its precursor lesions
Mark Ettel et al.
PATHOLOGY (2019)
Mutated WT1, FLT3-ITD, and NUP98-NSD1 Fusion in Various Combinations Define a Poor Prognostic Group in Pediatric Acute Myeloid Leukemia
Naghmeh Niktoreh et al.
JOURNAL OF ONCOLOGY (2019)
CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway
Shuhua Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Identification of LEM-14 inhibitor of the oncoprotein NSD2
Yunpeng Shen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Dasatinib and navitoclax act synergistically to target NUP98-NSD1+/FLT3-ITD+ acute myeloid leukemia
Jarno L. Kivioja et al.
LEUKEMIA (2019)
Integrated Analysis of Genetic Abnormalities of the Histone Lysine Methyltransferases in Prostate Cancer
Yangjun Zhang et al.
MEDICAL SCIENCE MONITOR (2019)
Epigenetic modifications of histones in cancer
Zibo Zhao et al.
GENOME BIOLOGY (2019)
Mutational analysis of head and neck squamous cell carcinoma stratified by smoking status
Farhad Ghasemi et al.
JCI INSIGHT (2019)
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
Yuan Cheng et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2019)
Investigations on small molecule inhibitors targeting the histone H3K4 tri-methyllysine binding PHD-finger of JmjC histone demethylases
Bhaskar Bhushan et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Disruption of NSD1 in Head and Neck Cancer Promotes Favorable Chemotherapeutic Responses Linked to Hypomethylation
Nam Bui et al.
MOLECULAR CANCER THERAPEUTICS (2018)
The role of protein methyltransferases as potential novel therapeutic targets in squamous cell carcinoma of the head and neck
Vassiliki Saloura et al.
ORAL ONCOLOGY (2018)
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
Hartmut Doehner et al.
BLOOD (2017)
Non-coding RNAs as regulators in epigenetics
Jian-Wei Wei et al.
ONCOLOGY REPORTS (2017)
Nup98 recruits the Wdr82-Set1A/COMPASS complex to promoters to regulate H3K4 trimethylation in hematopoietic progenitor cells
Tobias M. Franks et al.
GENES & DEVELOPMENT (2017)
A Rhodium(III)-Based Inhibitor of Lysine-Specific Histone Demethylase 1 as an Epigenetic Modulator in Prostate Cancer Cells
Chao Yang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
BIX-01294 inhibits oncoproteins NSD1, NSD2 and NSD3
Masayo Morishita et al.
MEDICINAL CHEMISTRY RESEARCH (2017)
Impaired H3K36 methylation defines a subset of head and neck squamous cell carcinomas
Simon Papillon-Cavanagh et al.
NATURE GENETICS (2017)
A comprehensive review of lysine-specific demethylase 1 and its roles in cancer
Amir Hosseini et al.
EPIGENOMICS (2017)
AACR Project GENIE: Powering Precision Medicine through an International Consortium
Fabrice Andre et al.
CANCER DISCOVERY (2017)
Whole-exome sequencing reveals novel mutations and epigenetic regulation in hypopharyngeal carcinoma
Ping Wu et al.
ONCOTARGET (2017)
The Role of Nuclear Receptor-Binding SET Domain Family Histone Lysine Methyltransferases in Cancer
Richard L. Bennett et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
NSD1 inactivation defines an immune cold, DNA hypomethylated subtype in squamous cell carcinoma
Kevin Brennan et al.
SCIENTIFIC REPORTS (2017)
H3K36 methyltransferases as cancer drug targets: rationale and perspectives for inhibitor development
David S. Rogawski et al.
FUTURE MEDICINAL CHEMISTRY (2016)
A PWWP Domain of Histone-Lysine N-Methyltransferase NSD2 Binds to Dimethylated Lys-36 of Histone H3 and Regulates NSD2 Function at Chromatin
Saumya M. Sankaran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Identification of MYC mutations in acute myeloid leukemias with NUP98-NSD1 translocations
V-P Lavallee et al.
LEUKEMIA (2016)
Structural basis for PHDVC5HCHNSD1-C2HRNizp1 interaction: implications for Sotos syndrome
Andrea Berardi et al.
NUCLEIC ACIDS RESEARCH (2016)
Discovering and understanding oncogenic gene fusions through data intensive computational approaches
Natasha S. Latysheva et al.
NUCLEIC ACIDS RESEARCH (2016)
Dynamic behavior of the post-SET loop region of NSD1: Implications for histone binding and drug development
Sarah E. Graham et al.
PROTEIN SCIENCE (2016)
Cancer Statistics, 2015
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Comprehensive genomic characterization of head and neck squamous cell carcinomas
Michael S. Lawrence et al.
NATURE (2015)
NF-κB-dependent and -independent epigenetic modulation using the novel anti-cancer agent DMAPT
H. Nakshatri et al.
CELL DEATH & DISEASE (2015)
The NSD family of protein methyltransferases in human cancer
Theodore Vougiouklakis et al.
EPIGENOMICS (2015)
Potential of epigenetic therapies in the management of solid tumors
Victor Valdespino et al.
CANCER MANAGEMENT AND RESEARCH (2015)
Integrative and Comparative Genomic Analysis of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas
Tanguy Y. Seiwert et al.
CLINICAL CANCER RESEARCH (2015)
A Sensitive Luminescent Assay for the Histone Methyltransferase NSD1 and Other SAM-Dependent Enzymes
Katherine M. Drake et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2014)
NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report
Fabiana Ostronoff et al.
BLOOD (2014)
Potent co-operation between the NUP98-NSD1 fusion and the FLT3-ITD mutation in acute myeloid leukemia induction
Angeliki Thanasopoulou et al.
HAEMATOLOGICA (2014)
A Basic Post-SET Extension of NSDs Is Essential for Nucleosome Binding In Vitro
Abdellah Allali-Hassani et al.
JOURNAL OF BIOMOLECULAR SCREENING (2014)
The Methyltransferase NSD3 Has Chromatin-binding Motifs, PHD5-C5HCH, That Are Distinct from Other NSD (Nuclear Receptor SET Domain) Family Members in Their Histone H3 Recognition
Chao He et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
A rare but specific subset of adult AML patients can be defined by the cytogenetically cryptic NUP98-NSD1 fusion gene
A. Fasan et al.
LEUKEMIA (2013)
Analysis of NUP98/NSD1 translocations in adult AML and MDS patients
F. Thol et al.
LEUKEMIA (2013)
The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial-mesenchymal transition and invasive properties of prostate cancer
T. Ezponda et al.
ONCOGENE (2013)
SET for life biochemical activities and biological functions of SET domain-containing proteins
Hans-Martin Herz et al.
TRENDS IN BIOCHEMICAL SCIENCES (2013)
Sotos Syndrome Is Associated with Deregulation of the MAPK/ERK-Signaling Pathway
Remco Visser et al.
PLOS ONE (2012)
NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern
Iris H. I. M. Hollink et al.
BLOOD (2011)
The Structure of NSD1 Reveals an Autoregulatory Mechanism Underlying Histone H3K36 Methylation
Qi Qiao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
An open and shut case for the role of NSD proteins as oncogenes
Agda Karina Lucio-Eterovic et al.
TRANSCRIPTION-AUSTIN (2011)
Regulation of NF-κB by NSD1/FBXL11-dependent reversible lysine methylation of p65
Tao Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Role for the nuclear receptor-binding SET domain protein 1 (NSD1) methyltransferase in coordinating lysine 36 methylation at histone 3 with RNA polymerase II function
Agda Karina Lucio-Eterovic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Transcriptome-guided characterization of genomic rearrangements in a breast cancer cell line
Qi Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Epigenetic inactivation of the Sotos overgrowth syndrome gene histone methyltransferase NSD1 in human neuroblastoma and glioma
Maria Berdasco et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Risk of second primary cancer among patients with head and neck cancers: A pooled analysis of 13 cancer registries
Shu-Chun Chuang et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis
Gang G. Wang et al.
NATURE CELL BIOLOGY (2007)
NSD1 is essential for early post-implantation development and has a catalytically active SET domain
GV Rayasam et al.
EMBO JOURNAL (2003)
A novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15.5) in de novo childhood acute myeloid leukemia
RJ Jaju et al.
BLOOD (2001)
Share Paper
